Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead

Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June and what they heard at the meeting.

Episode metadata supplied by the publisher feed · Published Jul 5, 2024

Embed this episode

Attribution link and audio player

Ready to play

Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead

0:00 48:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 48 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on July 5, 2024.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!